Primobolan or masteron for women?

Primobolan preferable. Its low androgenicity (Saartok 1984) and favorable anabolic ratio allow use at 50-100 mg/week over 6-8 weeks with acceptable virilization risk. Masteron, even at 100 mg/week, causes virilization in ~25% of women (acne, deep voice, hirsutism) because of its DHT-derived profile. For competing women who accept this risk, masteron propionate over 4 weeks pre-contest remains used. For female recreational use, anavar or primobolan are safer.

Why is primobolan expensive?

Three reasons: (1) methenolone synthesis is complex and costly, without wide generic pharmaceutical alternative, (2) the underground market (UGL) is saturated with underdosed counterfeits (often sold as primobolan but actually masteron or testosterone), (3) authentic pharmaceutical primobolan (Schering Bayer) has become rare. Consequence: you often have to pay 100-150 €/vial of 10 mL for real methenolone, vs 40-60 € for equivalent testosterone. Lab tests useful before major purchase.

Does oral primobolan exist and is it effective?

Yes (Primobolan tabs, methenolone acetate), but ineffective in practice. Its oral bioavailability is very low (~40% after first-pass hepatic metabolism), and it is not 17α-alkylated so it metabolizes rapidly. To obtain a relevant anabolic dose, you would need 150-200 mg/day, a prohibitive cost. The injectable form (enanthate) is widely preferred because bioavailability is complete and kinetics stable. Oral primobolan is mainly a nostalgic product.

How much realistic gains with primobolan?

Modest but durable. Over 12 weeks at 500 mg/week + testo base 200 mg/week: +3 to +5 kg net lean mass retained at 3 months post-PCT. Primobolan does not cause water retention, so visible gains are almost exclusively muscular. It is the opposite of dianabol: less spectacular during cycle, but much better preserved after. Excellent profile for users who value long-term retention and hormonal health.

Do you need an AI with primobolan + masteron?

Often not, or at very low dose. Neither aromatizes (Kicman 2008), so estradiol comes only from the testo base. If testo stays at 200-300 mg/week, aromatization is manageable without AI or with anastrozole 0.25 mg 2× per week. If testo rises to 400-500 mg/week, anastrozole 0.5 mg 2× per week. Masteron functionally compensates a slight E2 elevation by its receptor competition. E2 monitoring measured at W4 and W8.

What PCT after primobolan + masteron + testo?

Simpler than after a 19-nor cycle. Start 2-3 weeks after last long ester injection. Scheme: hCG 1500 IU EOD × 7-10 days to restart testicles, then nolvadex 40/20/20/20 mg or clomid 50/25/25/25 mg × 4 weeks (Rahnema 2014). T total, LH, FSH panel at W6 post-PCT. Recovery typically complete at 6-8 weeks thanks to moderate primobolan and masteron suppression.

Primobolan or anavar for cutting?

Case by case. Injectable primobolan offers excellent tolerance profile on long cycles (12+ weeks), no hepatic toxicity, but high cost. Oral anavar offers practical anti-catabolic effect on short cycles (6-8 weeks), easy to dose, but real hepatotoxicity and degraded lipid profile. For female athletes: anavar (5-10 mg/d) or primobolan (50-100 mg/week). For men on long cycle: primobolan. For oral cutting kickstart: anavar. Neither cuts alone: caloric deficit and cardio remain the pillars.

Is primobolan really 'safe'?

Relatively, but not harmless. Pollen 1980 and the historical corpus of therapeutic use in children and women suggest a tolerance profile superior to the AAS average, but primobolan remains an anabolic steroid: moderate but real HPG suppression, degraded lipid profile (HDL crash), androgenic risk in predisposed users. The 'primo = safe' myth leads some users to abuse doses (> 800 mg/week) thinking they are protected, which cancels the tolerance advantage. Respect 400-600 mg/week as normal dose.

Primobolan vs Masteron: complete comparison (cutting, mild profile, hardness)

Critère	primobolan	masteron
Anabolic/androgenic ratio	88:44	62:25
Half-life	~5 d (enanthate)	2 d (prop) / 5 d (enanthate)
Aromatization	No	No (DHT-derivative)
Hepatotoxicity	Low (injection)	Low (injection)
HPG axis suppression	Mild to moderate	Moderate
Typical dose	400-600 mg/week	400-600 mg/week
Visual effect	Mild gain, quality	Hardness, vascularity
Female tolerance	Good at 50-100 mg/week	Moderate at 100-150 mg/week

Quand choisir primobolan

Primobolan (methenolone enanthate) is the mildest injectable AAS in the landscape. Pollen 1980 documented its clinical use in aplastic anemia with exceptional tolerance profile — it is one of the rare anabolic steroids that survived decades of therapeutic use without major reported toxicity. Choose it when seeking: (1) a long cycle (12-16 weeks) without accumulating suppression or toxicity, (2) a cycle for women with acceptable virilization safety margin (50-100 mg/week), (3) a 'bridge' between more aggressive cycles to recover without losing all gains, (4) a quality supplement to a testosterone base for adding clean mass without retention. Moderate anabolic/androgenic ratio (88:44, Saartok 1984) means little raw gain but few androgenic side effects (acne, hair). No aromatization (Kicman 2008), so no AI needed. Moderate HPG axis suppression, shorter PCT (4 weeks suffice). Typical dose 400-600 mg/week in enanthate (2 injections per week) over 12-16 weeks. Main drawback: high price (pharmaceutical primobolan is rare, UGL often underdosed), and modest visible gains — not for users who want to see rapid changes.

Quand choisir masteron

Masteron (drostanolone) is a DHT-derivative oriented toward aesthetic finish (Chowdhury 1976, Saartok 1984). Choose it when you want to add visual hardness, vascularity and a mild anti-estrogenic effect to a cutting cycle. Its distinctive mechanism: marked displacement of testosterone from SHBG (free testo increase), competition at the estrogen receptor (functional anti-E2 effect without aromatase inhibition), and DHT-like activity on the skin (dryness, finish). Modest anabolic profile (ratio 62:25): it does not make you grow, it defines. Ideal in the last 8-10 weeks before competition or to finish a cycle. Favorable tolerance profile (Kicman 2008): no aromatization, low hepatotoxicity (injection), moderate suppression. Drawbacks: marked androgenic profile so acne and hair loss possible in predisposed users, and visual effect apparent only if body fat is already < 12% (masteron does not cut, it polishes). Typical dose 400-600 mg/week in propionate (3× per week) or enanthate (2× per week). For women, 100-150 mg/week maximum on short cycles (4-6 weeks) with virilization monitoring.

Combinaison ?

The primobolan + masteron combo is a major classic of mild cutting: primobolan enanthate 400 mg/week + masteron enanthate 400 mg/week + testosterone base 200-300 mg/week over 10-12 weeks. Primobolan brings muscle quality and mild anabolic effect, masteron the hardness and functional anti-estrogen effect, testosterone the complete androgenic function and some mass. No strong AI necessary (moderate testo + masteron anti-E2), anastrozole 0.25 mg 2× per week as precaution. Excellent tolerance profile: little retention, little brutal suppression, standard monitoring (lipids, hematocrit, T total at W0, W6, W12). PCT 3 weeks after last injection, hCG + SERM 4 weeks suffice. Ideal for intermediate users who want a competitive cut without stacking trenbolone toxicity. Higher cost than other combos (expensive primobolan), but excellent gains/side effects ratio. Sample 12-week mild-cut timeline: W0 baseline lipids/T total, W2 first injection rotation check, W4 E2 and lipids, W6 mid-cycle full panel, W8 lipids recheck, W10 contest-prep dose adjustment if needed, W12 last injection, W14 PCT start, W20 post-PCT confirmation. Injection scheduling practical tip: when running primo + masteron + low-dose testo, target 6-8 weekly injections total across rotating sites (deltoids, glutes, quads) for stable serum levels. Primobolan injection volume warning: typical 100 mg/mL concentration means at 500 mg/week you inject 5 mL split across the week — site rotation discipline matters. Cost optimization: real pharma primo + UGL masteron is a common practical hybrid given the primo authenticity premium.

FAQ

Primobolan or masteron for women?: Primobolan preferable. Its low androgenicity (Saartok 1984) and favorable anabolic ratio allow use at 50-100 mg/week over 6-8 weeks with acceptable virilization risk. Masteron, even at 100 mg/week, causes virilization in ~25% of women (acne, deep voice, hirsutism) because of its DHT-derived profile. For competing women who accept this risk, masteron propionate over 4 weeks pre-contest remains used. For female recreational use, anavar or primobolan are safer.
Why is primobolan expensive?: Three reasons: (1) methenolone synthesis is complex and costly, without wide generic pharmaceutical alternative, (2) the underground market (UGL) is saturated with underdosed counterfeits (often sold as primobolan but actually masteron or testosterone), (3) authentic pharmaceutical primobolan (Schering Bayer) has become rare. Consequence: you often have to pay 100-150 €/vial of 10 mL for real methenolone, vs 40-60 € for equivalent testosterone. Lab tests useful before major purchase.
Does oral primobolan exist and is it effective?: Yes (Primobolan tabs, methenolone acetate), but ineffective in practice. Its oral bioavailability is very low (~40% after first-pass hepatic metabolism), and it is not 17α-alkylated so it metabolizes rapidly. To obtain a relevant anabolic dose, you would need 150-200 mg/day, a prohibitive cost. The injectable form (enanthate) is widely preferred because bioavailability is complete and kinetics stable. Oral primobolan is mainly a nostalgic product.
How much realistic gains with primobolan?: Modest but durable. Over 12 weeks at 500 mg/week + testo base 200 mg/week: +3 to +5 kg net lean mass retained at 3 months post-PCT. Primobolan does not cause water retention, so visible gains are almost exclusively muscular. It is the opposite of dianabol: less spectacular during cycle, but much better preserved after. Excellent profile for users who value long-term retention and hormonal health.
Do you need an AI with primobolan + masteron?: Often not, or at very low dose. Neither aromatizes (Kicman 2008), so estradiol comes only from the testo base. If testo stays at 200-300 mg/week, aromatization is manageable without AI or with anastrozole 0.25 mg 2× per week. If testo rises to 400-500 mg/week, anastrozole 0.5 mg 2× per week. Masteron functionally compensates a slight E2 elevation by its receptor competition. E2 monitoring measured at W4 and W8.
What PCT after primobolan + masteron + testo?: Simpler than after a 19-nor cycle. Start 2-3 weeks after last long ester injection. Scheme: hCG 1500 IU EOD × 7-10 days to restart testicles, then nolvadex 40/20/20/20 mg or clomid 50/25/25/25 mg × 4 weeks (Rahnema 2014). T total, LH, FSH panel at W6 post-PCT. Recovery typically complete at 6-8 weeks thanks to moderate primobolan and masteron suppression.
Primobolan or anavar for cutting?: Case by case. Injectable primobolan offers excellent tolerance profile on long cycles (12+ weeks), no hepatic toxicity, but high cost. Oral anavar offers practical anti-catabolic effect on short cycles (6-8 weeks), easy to dose, but real hepatotoxicity and degraded lipid profile. For female athletes: anavar (5-10 mg/d) or primobolan (50-100 mg/week). For men on long cycle: primobolan. For oral cutting kickstart: anavar. Neither cuts alone: caloric deficit and cardio remain the pillars.
Is primobolan really 'safe'?: Relatively, but not harmless. Pollen 1980 and the historical corpus of therapeutic use in children and women suggest a tolerance profile superior to the AAS average, but primobolan remains an anabolic steroid: moderate but real HPG suppression, degraded lipid profile (HDL crash), androgenic risk in predisposed users. The 'primo = safe' myth leads some users to abuse doses (> 800 mg/week) thinking they are protected, which cancels the tolerance advantage. Respect 400-600 mg/week as normal dose.

Primobolan vs Masteron: complete comparison (cutting, mild profile, hardness)

Critère	primobolan	masteron
Anabolic/androgenic ratio	88:44	62:25
Half-life	~5 d (enanthate)	2 d (prop) / 5 d (enanthate)
Aromatization	No	No (DHT-derivative)
Hepatotoxicity	Low (injection)	Low (injection)
HPG axis suppression	Mild to moderate	Moderate
Typical dose	400-600 mg/week	400-600 mg/week
Visual effect	Mild gain, quality	Hardness, vascularity
Female tolerance	Good at 50-100 mg/week	Moderate at 100-150 mg/week

Quand choisir primobolan

Quand choisir masteron

Combinaison ?

FAQ

Primobolan or masteron for women?: Primobolan preferable. Its low androgenicity (Saartok 1984) and favorable anabolic ratio allow use at 50-100 mg/week over 6-8 weeks with acceptable virilization risk. Masteron, even at 100 mg/week, causes virilization in ~25% of women (acne, deep voice, hirsutism) because of its DHT-derived profile. For competing women who accept this risk, masteron propionate over 4 weeks pre-contest remains used. For female recreational use, anavar or primobolan are safer.
Why is primobolan expensive?: Three reasons: (1) methenolone synthesis is complex and costly, without wide generic pharmaceutical alternative, (2) the underground market (UGL) is saturated with underdosed counterfeits (often sold as primobolan but actually masteron or testosterone), (3) authentic pharmaceutical primobolan (Schering Bayer) has become rare. Consequence: you often have to pay 100-150 €/vial of 10 mL for real methenolone, vs 40-60 € for equivalent testosterone. Lab tests useful before major purchase.
Does oral primobolan exist and is it effective?: Yes (Primobolan tabs, methenolone acetate), but ineffective in practice. Its oral bioavailability is very low (~40% after first-pass hepatic metabolism), and it is not 17α-alkylated so it metabolizes rapidly. To obtain a relevant anabolic dose, you would need 150-200 mg/day, a prohibitive cost. The injectable form (enanthate) is widely preferred because bioavailability is complete and kinetics stable. Oral primobolan is mainly a nostalgic product.
How much realistic gains with primobolan?: Modest but durable. Over 12 weeks at 500 mg/week + testo base 200 mg/week: +3 to +5 kg net lean mass retained at 3 months post-PCT. Primobolan does not cause water retention, so visible gains are almost exclusively muscular. It is the opposite of dianabol: less spectacular during cycle, but much better preserved after. Excellent profile for users who value long-term retention and hormonal health.
Do you need an AI with primobolan + masteron?: Often not, or at very low dose. Neither aromatizes (Kicman 2008), so estradiol comes only from the testo base. If testo stays at 200-300 mg/week, aromatization is manageable without AI or with anastrozole 0.25 mg 2× per week. If testo rises to 400-500 mg/week, anastrozole 0.5 mg 2× per week. Masteron functionally compensates a slight E2 elevation by its receptor competition. E2 monitoring measured at W4 and W8.
What PCT after primobolan + masteron + testo?: Simpler than after a 19-nor cycle. Start 2-3 weeks after last long ester injection. Scheme: hCG 1500 IU EOD × 7-10 days to restart testicles, then nolvadex 40/20/20/20 mg or clomid 50/25/25/25 mg × 4 weeks (Rahnema 2014). T total, LH, FSH panel at W6 post-PCT. Recovery typically complete at 6-8 weeks thanks to moderate primobolan and masteron suppression.
Primobolan or anavar for cutting?: Case by case. Injectable primobolan offers excellent tolerance profile on long cycles (12+ weeks), no hepatic toxicity, but high cost. Oral anavar offers practical anti-catabolic effect on short cycles (6-8 weeks), easy to dose, but real hepatotoxicity and degraded lipid profile. For female athletes: anavar (5-10 mg/d) or primobolan (50-100 mg/week). For men on long cycle: primobolan. For oral cutting kickstart: anavar. Neither cuts alone: caloric deficit and cardio remain the pillars.
Is primobolan really 'safe'?: Relatively, but not harmless. Pollen 1980 and the historical corpus of therapeutic use in children and women suggest a tolerance profile superior to the AAS average, but primobolan remains an anabolic steroid: moderate but real HPG suppression, degraded lipid profile (HDL crash), androgenic risk in predisposed users. The 'primo = safe' myth leads some users to abuse doses (> 800 mg/week) thinking they are protected, which cancels the tolerance advantage. Respect 400-600 mg/week as normal dose.